EDUCATION & MATERIALS
As of February 25, 2022, 552 million doses of COVID-19 vaccine have been given in the United States, more than 10.6 billion doses, worldwide. COVID-19 vaccines have met the FDA’s scientific standards for safety, effectiveness, and manufacturing quality. While side effects are possible, serious health events are rare and scientifically, vaccination benefits outweigh the known and potential risks.
For more information visit the CDC website.
CDC COVID-19 vaccination schedule for the primary series in the general population
*NOTE: The interval between the first and second dose of Pfizer and Moderna for ages 12 – 64 has been modified. The originally approved 3 or 4 week interval remains valid; however, newly available scientific data shows that a longer interval between the first and second primary doses, among individuals ages 12 – 64, may prove to have a greater immune response, and decrease adverse reactions particularly in males ages 12 -39.
This recommendation DOES NOT apply to individuals with immunocompromised conditions, ages 65 or older, or in communities where there is high transmission.
Individuals who received mRNA (Pfizer or Moderna) vaccines under previous guidelines remain well-protected, especially if they are fully up to date with their vaccines, including booster doses.